Do Endotypes Predict Response and Sequelae in OSA Patients
NCT: NCT04875364 · COMPLETED
Brief Summary
This study will investigate why some people have Obstructive Sleep Apnea (OSA) and how the underlying cause may relate to OSA manifestations (including sleepiness and high blood pressure) and response to different therapeutic approaches (ie CPAP, eszopiclone, and supplemental oxygen). Understanding why someone has OSA could affect how best to treat that individual, but may also have an impact on what problems the disease might cause.
Frequently Asked Questions
What is Do Endotypes Predict Response and Sequelae in OSA Patients?
Do Endotypes Predict Response and Sequelae in OSA Patients is a clinical trial registered under NCT04875364. Current status: COMPLETED.
What is the status of NCT04875364?
The current status of NCT04875364 (Do Endotypes Predict Response and Sequelae in OSA Patients) is: COMPLETED.
When did Do Endotypes Predict Response and Sequelae in OSA Patients start?
Do Endotypes Predict Response and Sequelae in OSA Patients started on 2020-08-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.